BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27981393)

  • 1. Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.
    Prakobsuk S; Sirilak S; Vipattawat K; Taweesedt PT; Sumethkul V; Kantachuvesiri S; Disthabanchong S
    Clin Exp Nephrol; 2017 Oct; 21(5):926-931. PubMed ID: 27981393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
    Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of mineral metabolism markers on renal transplant outcomes.
    Marcén R; Jimenez S; Fernández A; Galeano C; Villafruela JJ; Burgos FJ; Quereda C
    Transplant Proc; 2012 Nov; 44(9):2567-9. PubMed ID: 23146456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative hypophosphatemia early after transplantation is a predictor of good kidney graft function.
    Nakai K; Mitsuiki K; Kuroki Y; Nishiki T; Motoyama K; Nakano T; Kitazono T
    Clin Exp Nephrol; 2019 Sep; 23(9):1161-1168. PubMed ID: 31214874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
    Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
    Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients.
    Barros X; Torregrosa JV; Martínez de Osaba MJ; Casals G; Paschoalin R; Durán CE; Campistol JM
    Transplantation; 2012 Oct; 94(8):830-6. PubMed ID: 23018879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal phosphate loss in long-term kidney transplantation.
    Sirilak S; Chatsrisak K; Ingsathit A; Kantachuvesiri S; Sumethkul V; Stitchantrakul W; Radinahamed P; Disthabanchong S
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):323-31. PubMed ID: 22134626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.
    Wolf M; Weir MR; Kopyt N; Mannon RB; Von Visger J; Deng H; Yue S; Vincenti F
    Transplantation; 2016 Jan; 100(1):184-93. PubMed ID: 26177089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
    Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC
    Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.
    Pihlstrøm H; Dahle DO; Mjøen G; Pilz S; März W; Abedini S; Holme I; Fellström B; Jardine AG; Holdaas H
    Transplantation; 2015 Feb; 99(2):351-9. PubMed ID: 25594550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.
    Evenepoel P; Meijers BK; de Jonge H; Naesens M; Bammens B; Claes K; Kuypers D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1829-36. PubMed ID: 18922992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia.
    Han SY; Hwang EA; Park SB; Kim HC; Kim HT
    Transplant Proc; 2012 Apr; 44(3):657-60. PubMed ID: 22483462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study.
    Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Ando K; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
    Ther Apher Dial; 2011 Oct; 15(5):481-7. PubMed ID: 21974702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
    Wesseling-Perry K; Tsai EW; Ettenger RB; Jüppner H; Salusky IB
    Nephrol Dial Transplant; 2011 Nov; 26(11):3779-84. PubMed ID: 21441401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.
    Oh IH; Lee CH; Kim GH; Kang CM; Park JS
    Artif Organs; 2015 Mar; 39(3):254-9. PubMed ID: 25205383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients.
    Evenepoel P; Naesens M; Claes K; Kuypers D; Vanrenterghem Y
    Am J Transplant; 2007 May; 7(5):1193-200. PubMed ID: 17359508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Hypercalcemic Hyperparathyroidism After Kidney Transplantation Is Associated With Improved Allograft Survival.
    Wang R; Reed RD; Price G; Abraham P; Lewis M; McMullin JL; MacLennan P; Killian C; Locke JE; Ong S; Kumar V; Gillis A; Lindeman B; Chen H; Fazendin J
    Oncologist; 2024 Apr; 29(4):e467-e474. PubMed ID: 38006197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.
    van Londen M; Aarts BM; Deetman PE; van der Weijden J; Eisenga MF; Navis G; Bakker SJL; de Borst MH;
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1301-1310. PubMed ID: 28546442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.